INDIA
COVOVAX Clinical Trials Begins in India: ICMR Partners With Serum Institute of India For Conducting Phase 2/3 Bridging Clinical Trial Of COVID-19 Vaccine
ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.
ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.
ICMR has partnered with @SerumInstIndia to conduct phase 2/3 bridging clinical trial of #COVOVAX. First three volunteers have been recruited today under the ICMR-SII NOVAVAX bridging study led by @IcmrNari at Nobel Hospital, Pune. @MoHFW_INDIA @DeptHealthRes @PIB_India pic.twitter.com/qxVf3dXJxz
— ICMR (@ICMRDELHI) March 25, 2021
(The above story first appeared on LatestLY on Mar 28, 2021 09:20 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
